immune system
|
• reduced TNF secretion in response to the TLR9 ligand CpG oligodeoxynucleotides (CpG ODN) primed with IFN and the TLR7 ligand R848
|
Analysis Tools|
Allele Symbol Allele Name Allele ID |
Myd88+ wild type MGI:2436005 |
||||||||||||||||||||||||||||
| Summary |
6 genotypes
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• reduced TNF secretion in response to the TLR9 ligand CpG oligodeoxynucleotides (CpG ODN) primed with IFN and the TLR7 ligand R848
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
| N |
• immunoblot analysis of lysates of heterozygous mutant mouse embryonic fibroblasts (MEFs) using antibody to IkappaB demonstrates normal degradation by these cells of IkappaB in response to interleukin 1 (IL-1)
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
| N |
• normal Ig class switching in germinal center B cells after immunization with hapten-carrier conjugate NP-CGG
• normal rise and fall of hapten-specific IgG levels after immunization with hapten-carrier conjugate NP-CGG
|
|
• increased frequency in IgM+ plasma cells
|
|
• increased frequency and number
|
|
• persistently high number of hapten-specific IgM+ plasma cells in spleen and bone marrow for at least 50 weeks after immunization with hapten-carrier conjugate NP-CGG
• high total plasma cell numbers in spleen and bone marrow for at least 50 weeks after immunization with hapten-carrier conjugate NP-CGG
|
|
• increased frequency and number of plasma cells and germinal center B cells
|
|
• high total IgM serum levels for at least 50 weeks after immunization with hapten-carrier conjugate NP-CGG
• persistently high hapten-specific IgM levels for at least 50 weeks after immunization with hapten-carrier conjugate NP-CGG
|
|
• increased frequency in IgM+ plasma cells
|
|
• increased frequency and number
|
|
• persistently high number of hapten-specific IgM+ plasma cells in spleen and bone marrow for at least 50 weeks after immunization with hapten-carrier conjugate NP-CGG
• high total plasma cell numbers in spleen and bone marrow for at least 50 weeks after immunization with hapten-carrier conjugate NP-CGG
|
|
• increased frequency and number of plasma cells and germinal center B cells
|
|
• high total IgM serum levels for at least 50 weeks after immunization with hapten-carrier conjugate NP-CGG
• persistently high hapten-specific IgM levels for at least 50 weeks after immunization with hapten-carrier conjugate NP-CGG
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
| monoclonal gammopathy of uncertain significance | DOID:7442 | J:308792 | ||
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• 15x increase in spleen 10 days after tamoxifen tre
• persistently high number of IgM+ plasma cells in spleen and bone marrow for at least 70 weeks after tamoxifen treatment
|
|
• high total IgM serum levels for at least 70 weeks after tamoxifen treatment, displaying discrete paraprotein bands in the gamma-globulin zone upon serum protein electrophoresis
|
|
• 15x increase in spleen 10 days after tamoxifen tre
• persistently high number of IgM+ plasma cells in spleen and bone marrow for at least 70 weeks after tamoxifen treatment
|
|
• high total IgM serum levels for at least 70 weeks after tamoxifen treatment, displaying discrete paraprotein bands in the gamma-globulin zone upon serum protein electrophoresis
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
| monoclonal gammopathy of uncertain significance | DOID:7442 | J:308792 | ||
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
| N |
• normal B cell development in bone marrow
• normal Ig class switching in B cells in spleen, mesenteric lymph nodes and Peyers patches
|
|
• from age 30 weeks
|
|
• increased frequency and number from age 30 weeks, increasing over time
|
|
• increased number of IgM+ plasma cells
• increased plasma cell compartment in spleen and bone marrow
• increased frequency and number of TACI+ CD138+ plasma cells from age 50 weeks
|
|
• increased frequency and number of germinal center B cells from age 30 weeks, increasing over time
• normal frequency of follicular and marginal zone B cells
|
|
• increased serum levels from age 10 weeks, increasing over time
|
|
• from age 30 weeks
|
|
• increased frequency and number from age 30 weeks, increasing over time
|
|
• increased number of IgM+ plasma cells
• increased plasma cell compartment in spleen and bone marrow
• increased frequency and number of TACI+ CD138+ plasma cells from age 50 weeks
|
|
• increased frequency and number of germinal center B cells from age 30 weeks, increasing over time
• normal frequency of follicular and marginal zone B cells
|
|
• increased serum levels from age 10 weeks, increasing over time
|
|
• from age 30 weeks
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• in cultured bone marrow dendritic cells from mice infected with Trypanosoma cruzi the number of trypomastigotes released into the supernatant is slightly increased and the replication within macrophages is slightly enhanced compared to controls
• slight increase in the number of trypomastigotes in the serum of T. cruzi infected mice
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 01/06/2026 MGI 6.24 |
|
|
|
||


